Actavis And Bioton Finally Get Around To Signing Insulins Deal

BMI View: We believe the long-awaited formation of a joint venture (JV) between Actavis and Bioton in the field of insulin production and commercialisation is highly favourable for both companies. However, we highlight that this deal has taken an exceptionally long time to complete and that has aggravated investors in the Polish firm.

To read the full article, please choose one of the following options: